Shire (SHPG) Scaled Net Operating Assets : 0.79 (As of Sep. 2018)

View and export this data going back to 1998. Start your Free Trial

What is Shire Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shire's operating assets for the quarter that ended in Sep. 2018 was $63,573 Mil. Shire's operating liabilities for the quarter that ended in Sep. 2018 was $11,129 Mil. Shire's Total Assets for the quarter that ended in Jun. 2018 was $66,222 Mil. Therefore, Shire's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2018 was 0.79.

Shire Scaled Net Operating Assets Historical Data

The historical data trend for Shire's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Scaled Net Operating Assets Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.43

0.79

0.83

3.09

0.82

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.79	0.82	0.82	0.80	0.79

Competitive Comparison of Shire's Scaled Net Operating Assets

For the Biotechnology subindustry, Shire's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shire's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shire's Scaled Net Operating Assets falls into.

Shire Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shire's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2017 )
=	(Operating Assets (A: Dec. 2017 )	-	Operating Liabilities (A: Dec. 2017 ))	/	Total Assets (A: Dec. 2016 )
=	(67284.5	-	12039.4)	/	67035.4
=	0.82

where

	Operating Assets		(A: Dec. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	67756.9	-	472.4
=	67284.5

	Operating Liabilities		(A: Dec. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	31580.5	-	16752.4	-	2788.7
=	12039.4

Shire's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2018 )
=	(Operating Assets (Q: Sep. 2018 )	-	Operating Liabilities (Q: Sep. 2018 ))	/	Total Assets (Q: Jun. 2018 )
=	(63572.7	-	11129)	/	66222.1
=	0.79

where

	Operating Assets		(Q: Sep. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	63765.9	-	193.2
=	63572.7

	Operating Liabilities		(Q: Sep. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	26475.7	-	11098	-	4248.7
=	11129

Shire Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shire's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shire (SHPG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Executives

James H Cavanaugh

director

265 HOTHORPE LANE, VILLANOVA PA 19085